CD70-targeted immunoPET Imaging of Malignant Cancers

Clinical trial NCT06852638 · RECRUITING

Trial details

NCT number: NCT06852638
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cancer Renal Clear Cell Carcinoma Lymphoma Lymphoma, Large B-Cell, Diffuse Follicular Lymphoma Mantle Cell Lymphoma Nasopharyngeal Carcinoma

Start date: 2024-12-23
Primary completion: 2026-12-23
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.